glp-1 receptor agonist use and risk of suicide death A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased depression symptoms. Rates of suicidal ideation behavior were low and similar to Postmarket safety profile of suicide/self-injury
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8



























